PenderFund Capital Management Ltd.
Position in XENE — Xenon Pharmaceuticals Inc.
CIK 1706164
VANCOUVER, A1
Position in XENE
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$413,466
+$15,139 QoQ
Shares Held
6,850
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#217
of 314 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PenderFund Capital Management Ltd. holds $1,699,256 across 5 Biotechnology names. XENE ranks #2 (24.3% of the industry book) .
All Filings in XENE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $413,466 | 6,850 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $398,327 | 6,850 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $307,017 | 6,850 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $275,027 | 6,850 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||